On June 13, 2024, Beijing Jiukang Healthcare (00648) announced that the company had signed a loan capitalization agreement with subscribers...
According to the loan capitalization agreement, the subscriber will subscribe for 900 million shares of loan capitalization shares at a price of HKD 0.01 per share and convertible bonds with a principal of HKD 6 million, which can be converted into 600 million shares of CN convertible shares at a price of HKD 0.01 per share. The loan capitalization price is HKD 0.01, a discount of 97.4% from the closing price of HKD 0.38 per share reported on the final trading day on the Stock Exchange of Hong Kong. After the loan capitalization is completed, all liabilities under the subscriber's loan will be deemed fully paid, settled and waived.
Upon completion of the loan capitalization, the subscriber agreed to waive the accumulated interest on the loan. In addition, the subscriber also agreed that from the date of approval of the loan capitalization agreement by a special shareholders' meeting, it will provide the company with an additional loan of up to HKD 10 million (additional loan), which the company can withdraw before December 31, 2024. The additional loan is unsecured, interest-free, and must be repaid on or before December 31, 2025, and does not carry any share conversion rights.
Smart Noble Holdings Limited, owned by Zhou Guangyou, fully owns the subscriber.
The announcement stated that the total and net proceeds from loan capitalization were HKD 15 million and HKD 14.8 million, respectively. The company has/ plans to use the net proceeds to pay for the company and administrative expenses related to daily operations, resumption of trading, and planned costs; and as working capital for medical and health businesses.
Zhao Guangyou owns Smart Noble Holdings Limited entirely, which is the subscriber.